Logo image of IVDA

IVEDA SOLUTIONS INC (IVDA) Stock Fundamental Analysis

NASDAQ:IVDA - Nasdaq - US46583A3032 - Common Stock - Currency: USD

1.84  -0.17 (-8.46%)

After market: 1.87 +0.03 (+1.63%)

Fundamental Rating

2

Overall IVDA gets a fundamental rating of 2 out of 10. We evaluated IVDA against 284 industry peers in the Software industry. IVDA has a bad profitability rating. Also its financial health evaluation is rather negative. IVDA is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IVDA has reported negative net income.
IVDA had a negative operating cash flow in the past year.
IVDA had negative earnings in each of the past 5 years.
In the past 5 years IVDA always reported negative operating cash flow.
IVDA Yearly Net Income VS EBIT VS OCF VS FCFIVDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M -5M

1.2 Ratios

The Return On Assets of IVDA (-80.96%) is worse than 88.38% of its industry peers.
Looking at the Return On Equity, with a value of -215.55%, IVDA is doing worse than 80.28% of the companies in the same industry.
Industry RankSector Rank
ROA -80.96%
ROE -215.55%
ROIC N/A
ROA(3y)-58.84%
ROA(5y)-80.97%
ROE(3y)-97.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVDA Yearly ROA, ROE, ROICIVDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2019 2020 2021 2022 2023 2024 0 200 400

1.3 Margins

Looking at the Gross Margin, with a value of 19.70%, IVDA is doing worse than 81.69% of the companies in the same industry.
IVDA's Gross Margin has declined in the last couple of years.
IVDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.62%
GM growth 5Y-5.06%
IVDA Yearly Profit, Operating, Gross MarginsIVDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

IVDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
IVDA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for IVDA has been increased compared to 5 years ago.
Compared to 1 year ago, IVDA has a worse debt to assets ratio.
IVDA Yearly Shares OutstandingIVDA Yearly Shares OutstandingYearly Shares Outstanding 2015 2019 2020 2021 2022 2023 2024 5M 10M 15M
IVDA Yearly Total Debt VS Total AssetsIVDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

Based on the Altman-Z score of -16.14, we must say that IVDA is in the distress zone and has some risk of bankruptcy.
IVDA has a worse Altman-Z score (-16.14) than 91.20% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that IVDA is not too dependend on debt financing.
IVDA's Debt to Equity ratio of 0.47 is on the low side compared to the rest of the industry. IVDA is outperformed by 63.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z -16.14
ROIC/WACCN/A
WACC9.98%
IVDA Yearly LT Debt VS Equity VS FCFIVDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

2.3 Liquidity

IVDA has a Current Ratio of 1.80. This is a normal value and indicates that IVDA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.80, IVDA is in line with its industry, outperforming 56.34% of the companies in the same industry.
IVDA has a Quick Ratio of 1.71. This is a normal value and indicates that IVDA is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of IVDA (1.71) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.71
IVDA Yearly Current Assets VS Current LiabilitesIVDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for IVDA have decreased strongly by -23.55% in the last year.
Looking at the last year, IVDA shows a very strong growth in Revenue. The Revenue has grown by 54.30%.
Measured over the past years, IVDA shows a quite strong growth in Revenue. The Revenue has been growing by 10.59% on average per year.
EPS 1Y (TTM)-23.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.46%
Revenue 1Y (TTM)54.3%
Revenue growth 3Y46.37%
Revenue growth 5Y10.59%
Sales Q2Q%326.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y264.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year229.89%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IVDA Yearly Revenue VS EstimatesIVDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
IVDA Yearly EPS VS EstimatesIVDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 -0.5 -1 -1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IVDA. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 7.84, the valuation of IVDA can be described as very cheap.
Based on the Price/Forward Earnings ratio, IVDA is valued cheaper than 94.37% of the companies in the same industry.
IVDA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.29.
Industry RankSector Rank
PE N/A
Fwd PE 7.84
IVDA Price Earnings VS Forward Price EarningsIVDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVDA Per share dataIVDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

IVDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IVDA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IVEDA SOLUTIONS INC

NASDAQ:IVDA (6/25/2025, 8:00:02 PM)

After market: 1.87 +0.03 (+1.63%)

1.84

-0.17 (-8.46%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-12 2025-08-12/bmo
Inst Owners2.98%
Inst Owner Change-48.59%
Ins Owners4.74%
Ins Owner Change0%
Market Cap5.17M
Analysts82.86
Price TargetN/A
Short Float %0.55%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-77.61%
Min Revenue beat(2)-85.34%
Max Revenue beat(2)-69.88%
Revenue beat(4)0
Avg Revenue beat(4)-50.25%
Min Revenue beat(4)-85.34%
Max Revenue beat(4)-5.95%
Revenue beat(8)0
Avg Revenue beat(8)-55.35%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.84
P/S 0.72
P/FCF N/A
P/OCF N/A
P/B 3.04
P/tB 3.04
EV/EBITDA N/A
EPS(TTM)-1.48
EYN/A
EPS(NY)0.23
Fwd EY12.75%
FCF(TTM)-1.16
FCFYN/A
OCF(TTM)-1.22
OCFYN/A
SpS2.54
BVpS0.61
TBVpS0.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -80.96%
ROE -215.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.7%
FCFM N/A
ROA(3y)-58.84%
ROA(5y)-80.97%
ROE(3y)-97.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.62%
GM growth 5Y-5.06%
F-Score3
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.71
Altman-Z -16.14
F-Score3
WACC9.98%
ROIC/WACCN/A
Cap/Depr(3y)163.5%
Cap/Depr(5y)131.43%
Cap/Sales(3y)0.53%
Cap/Sales(5y)0.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.46%
EPS Next Y264.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)54.3%
Revenue growth 3Y46.37%
Revenue growth 5Y10.59%
Sales Q2Q%326.18%
Revenue Next Year229.89%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year292.8%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.19%
OCF growth 3YN/A
OCF growth 5YN/A